. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Vascul Pharmacol. 2018 Feb 15;106:37–45. doi: 10.1016/j.vph.2018.02.004

Table 3.

Potency and efficacy of tyramine in renal arteries + and − PVAT from the sham renal denervated (Sham RDN) and denervated (RDN) rats. Points are means±SEM for number of animals indicated on figure 8.

	+PVAT		−PVAT
	−log EC₅₀ [M]	Max	−log EC₅₀ [M]	Max
Sham RDN	4.05±0.17	56.40±11.61	3.81±0.06	20.60±5.85*
RDN	4.24±0.10	47.62±5.48	3.95±0.15	15.51±5.50*

^•

= statistically significant differences (p<0.05) between + and − PVAT variable.